Search

loike

Genome Editing on Board
Genome Editing on Board
Bob Grant | Jan 1, 2019
2018 closed with hubbub surrounding the purported birth of babies whose genomes had been edited using CRISPR. What will 2019 hold for CRISPR’s use in humans?
Opinion: The Central Dogma of Mitochondrial Genetics Needs Rewriting
Opinion: The Central Dogma of Mitochondrial Genetics Needs Rewriting
John D. Loike | Dec 12, 2018
The recent discovery of 17 people who have inherited maternal and paternal lines of mitochondrial DNA has major ramifications for medical and ancestry research.
Opinion: Don’t Ban the Use of CRISPR in Embryos
Opinion: Don’t Ban the Use of CRISPR in Embryos
John D. Loike | Nov 29, 2018
Despite a premature and ethically sketchy claim of genome editing in twin girls, an outright prohibition could blunt promising, responsible progress.
Opinion: The New Frontiers of Epigenetics
Opinion: The New Frontiers of Epigenetics
John D. Loike | Nov 12, 2018
Newly developed techniques could propel a field already advancing rapidly to complement modern medicine.
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
Opinion: Consumer DNA Testing Is Crossing into Unethical Territories
John D. Loike | Aug 16, 2018
Data don’t support many direct-to-consumer products, from telomere assessments to bespoke diets based on genetic sequences.
Opinion: Three-Parent Embryos—A Slippery Slope?
Opinion: Three-Parent Embryos—A Slippery Slope?
John D. Loike, Alan Kadish | Jun 14, 2018
The use of pronuclear transfer to treat infertility must first be backed by evidence it can work in cases where parents seek to avoid mitochondrial mutations.
Opinion: Should Human-Animal Chimeras Be Granted “Personhood”?
Opinion: Should Human-Animal Chimeras Be Granted “Personhood”?
John D. Loike | May 23, 2018
Determining which products of advanced biotechnology are deserving of legal protections is essential to our own social architecture.
Contributors
Contributors
Ben Andrew Henry | Jan 1, 2017
Meet some of the people featured in the January 2017 issue of The Scientist.
Infographic: The Cost of Drug Development
Infographic: The Cost of Drug Development
John D. Loike and Jennifer Miller | Feb 1, 2017
Expensive clinical trials and few drug approvals can drive up drug prices for consumers.
Week in Review: January 30–February 3
Week in Review: January 30–February 3
Joshua A. Krisch | Feb 3, 2017
March for science debate; an RNA vaccine for Zika; responses to Trump’s immigration order; native habitat restoration; views from local March for Science organizers; artificial cells and the Turing test

Refine your Search

Search Again